Safety Shot (JUPW) Revenue & Revenue Breakdown
Safety Shot Revenue Highlights
Latest Revenue (Y)
$6.20M
Latest Revenue (Q)
$910.01K
Safety Shot Revenue by Period
Safety Shot Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2022-12-31 | $6.20M | 115.44% |
| 2021-12-31 | $2.88M | 169.90% |
| 2020-12-31 | $1.07M | 16409.14% |
| 2019-12-31 | $6.46K | - |
Safety Shot generated $6.20M in revenue during NA 2022, up 115.44% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Safety Shot Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-09-30 | $910.01K | -61.53% |
| 2023-06-30 | $2.37M | 110.87% |
| 2023-03-31 | $1.12M | 23.86% |
| 2022-12-31 | $905.61K | -42.32% |
| 2022-09-30 | $1.57M | -47.68% |
| 2022-06-30 | $3.00M | 315.81% |
| 2022-03-31 | $721.63K | -53.27% |
| 2021-12-31 | $1.54M | 124.50% |
| 2021-09-30 | $687.93K | 15.60% |
| 2021-06-30 | $595.09K | 1118.29% |
| 2021-03-31 | $48.85K | -84.34% |
| 2020-12-31 | $311.94K | 74.92% |
| 2020-09-30 | $178.34K | -61.03% |
| 2020-06-30 | $457.67K | 288.75% |
| 2020-03-31 | $117.73K | 210126.79% |
| 2019-12-31 | $56.00 | -98.90% |
| 2019-09-30 | $5.07K | 280.77% |
| 2019-06-30 | $1.33K | 100.00% |
| 2019-03-31 | - | - |
Safety Shot generated $910.01K in revenue during Q3 2023, up -61.53% compared to the previous quarter, and up 30.33% compared to the same period a year ago.
Safety Shot Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PBH | Prestige Consumer Healthcare | $1.13B | $267.14M |
| PAHC | Phibro Animal Health | $977.89M | $263.22M |
| COLL | Collegium Pharmaceutical | $566.77M | $144.92M |
| ANIP | ANI Pharmaceuticals | $486.82M | $138.04M |
| PROC | Procaps Group | $409.92M | $118.41M |
| EGRX | Eagle Pharmaceuticals | $316.61M | $64.65M |
| CPIX | Cumberland Pharmaceuticals | $39.55M | $9.85M |
| SSIC | Silver Spike Investment | $11.72M | $2.76B |
| JUPW | Safety Shot | $6.20M | $910.01K |
| IXHL | Incannex Healthcare | - | - |
| RGC | Regencell Bioscience | - | - |
JUPW Revenue FAQ
What is Safety Shot’s yearly revenue?
Safety Shot's yearly revenue for 2022 was $6.2M, representing an increase of 115.44% compared to 2021. The company's yearly revenue for 2021 was $2.88M, representing an increase of 169.90% compared to 2020. JUPW's yearly revenue for 2020 was $1.07M, representing an increase of 16409.14% compared to 2019.
What is Safety Shot’s quarterly revenue?
Safety Shot's quarterly revenue for Q3 2023 was $910.01K, a -61.53% decrease from the previous quarter (Q2 2023), and a -42.03% decrease year-over-year (Q3 2022). The company's quarterly revenue for Q2 2023 was $2.37M, a 110.87% increase from the previous quarter (Q1 2023), and a -21.17% decrease year-over-year (Q2 2022). JUPW's quarterly revenue for Q1 2023 was $1.12M, a 23.86% increase from the previous quarter (Q4 2022), and a 55.44% increase year-over-year (Q1 2022).
What is Safety Shot’s revenue growth rate?
Safety Shot's revenue growth rate for the last 3 years (2020-2022) was 481.49%